Lingtong New Materials key facts
- Provider and developer of hydroxyapatite (HA) products designed for medicine purification processes and medical implants.
- Notable investors include Suzhou Nanhui Zhongcheng Entrepreneurship Investment.
- Status: Privately Held (backing).
Who backs Lingtong New Materials
1- ·Watch Lingtong New Materials: the Monday email on marks, rounds and moves
Lingtong New Materials funding rounds
No funding rounds for Lingtong New Materials are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Lingtong New Materials investors
1 investor is on record for Lingtong New Materials, including Suzhou Nanhui Zhongcheng Entrepreneurship Investment.
About Lingtong New Materials
Provider and developer of hydroxyapatite (HA) products designed for medicine purification processes and medical implants. The company focuses on research, development and production of hydroxyapatite (HA) products, enabling clients with functional nano-materials.
- Sector
- Materials and Resources
- HQ
- Suzhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Lingtong New Materials doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.